Early noninvasive prenatal paternity testing by targeted fetal DNA analysis.

Détails

Ressource 1Télécharger: 41598_2023_Article_39367.pdf (2038.26 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_E8EC3180DA38
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Early noninvasive prenatal paternity testing by targeted fetal DNA analysis.
Périodique
Scientific reports
Auteur⸱e⸱s
Damour G., Baumer K., Legardeur H., Hall D.
ISSN
2045-2322 (Electronic)
ISSN-L
2045-2322
Statut éditorial
Publié
Date de publication
26/07/2023
Peer-reviewed
Oui
Volume
13
Numéro
1
Pages
12139
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Résumé
Today the challenge in paternity testing is to provide an accurate noninvasive assay that can be performed early during pregnancy. This requires the use of novel analytical methods capable of detecting the low fraction of circulating fetal DNA in maternal blood. We previously showed that forensic compound markers such as deletion/insertion polymorphisms-short tandem repeats (DIP-STR) can efficiently resolve complex mixed biological evidence including the target analysis of paternally inherited fetal alleles. In this study, we describe for the first time the validation of this type of markers in the first trimester of pregnancies, in addition to defining the statistical framework to evaluate paternity. To do so, we studied 47 DIP-STRs in 87 cases, with blood samples collected throughout gestation starting from the seven weeks of amenorrhea. Fetal DNA detection in the first trimester shows a false negative rate as low as 6%. The combined paternity index (CPI) results indicate that seven markers with fully informative genotypes are sufficient to determine the paternity. This study demonstrates that DIP-STR markers can be used from early pregnancy and that a small set of markers (about 40) is sufficient to address the question of paternity. The novel method offers substantial improvements over similar approaches in terms of reduced number of markers, lower costs and increased accuracy.
Mots-clé
Pregnancy, Female, Humans, Paternity, Polymorphism, Genetic, Noninvasive Prenatal Testing/methods, Fetus, DNA/genetics, Microsatellite Repeats/genetics, Cell-Free Nucleic Acids/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/07/2023 14:27
Dernière modification de la notice
04/10/2023 6:58
Données d'usage